GLP-1 drugs: what Nevada Medicaid paid

Q: Does a paid prescription mean Nevada Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Nevada Medicaid shows a published payment figure for 7 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Nevada Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Nevada Medicaid’s payment record shows

In 2026Q1, the product Nevada Medicaid paid for most often was Ozempic®, at 10,075 prescriptions¹⁹ of the 18,221 to 18,419^{1,7,13,19,25,37,43} across all 8 products, or 55 percent of the published count.

Nevada Medicaid itself reimbursed at least $19,717,947 for these products in the quarter, about $1,083 per prescription. Pharmacies were paid $23,262,610 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,165.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Nevada Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Nevada Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Nevada Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Nevada Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Both702 managed care, 141 direct	at least 843¹	5%	$803,620	$876,749	$953
tirzepatideMounjaro®	Both4,335 managed care, 1,744 direct	at least 6,079⁷	33%	$6,666,905	$8,300,722	$1,097
semaglutideWegovy®	Both316 managed care, 161 direct	at least 477¹³	3%	$555,623	$620,559	$1,165
semaglutideOzempic®	Both8,021 managed care, 2,054 direct	at least 10,075¹⁹	55%	$11,161,369	$12,768,074	$1,108
semaglutideRybelsus®	Both276 managed care, 141 direct	417²⁵	2%	$447,530	$613,005	$1,073
liraglutideSaxenda®	Not published	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	at least 14³⁷	<1%	$6,900	$6,900	$493
liraglutideliraglutide (generic)	Managed care	at least 294⁴³	2%	$76,000	$76,603	$259

Nevada Medicaid publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Against enrollment, that is 26.8 to 27.1 prescriptions per thousand people enrolled in Nevada Medicaid, on an average of 679,835 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 14 of the 168 product-quarters it holds a row for here, which is 8 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic® and Rybelsus® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Nevada Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Nevada Medicaid paid for each product, quarter by quarter

Prescriptions Nevada Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable²Withheld4 of 4 product codes withheld	at least 13 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$4,695 paid	at least 79 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$75,855 paid	at least 272 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$266,426 paid	at least 843 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$803,620 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	at least 23 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$18,428 paid	at least 267 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$269,888 paid	at least 531 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$541,246 paid	at least 689 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$778,664 paid	at least 603 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$715,032 paid	at least 696 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$819,819 paid	at least 1,629 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$1,833,596 paid	at least 2,166 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$2,435,778 paid	at least 2,868 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$3,257,443 paid	at least 3,091 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$3,703,223 paid	at least 3,762 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$4,048,502 paid	at least 4,745 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$5,378,266 paid	at least 5,152 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$6,198,198 paid	at least 5,517 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$6,735,583 paid	at least 6,079 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$6,666,905 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter¹⁶No row	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable¹⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable¹⁶Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter¹⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable¹⁵Withheld3 of 3 product codes withheld	at least 34 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$39,894 paid	at least 75 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$94,564 paid	at least 116 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$145,715 paid	at least 230 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$272,093 paid	at least 244 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$290,135 paid	at least 286 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$350,193 paid	at least 477 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$555,623 paid
semaglutideOzempic®range 9,820 to 11,420	at least 1,602 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$1,384,013 paid	at least 1,671 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$1,516,870 paid	at least 2,032 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$1,883,878 paid	at least 1,717 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$1,710,452 paid	at least 1,777 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$1,817,522 paid	at least 3,056 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$2,817,154 paid	at least 3,250 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$3,051,832 paid	at least 3,478 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$3,311,909 paid	at least 2,964 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$3,168,943 paid	at least 3,312 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$3,547,923 paid	at least 4,198 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$4,543,635 paid	at least 4,784 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$5,133,104 paid	at least 6,641 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$6,928,899 paid	at least 8,102 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$8,171,124 paid	at least 9,367 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$9,625,764 paid	at least 9,250 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$9,955,480 paid	at least 10,312 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$10,670,074 paid	11,420 paid prescriptions in the quarter (2025Q2)²⁰Count$12,105,005 paid	at least 10,850 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$11,909,186 paid	9,820 paid prescriptions in the quarter (2025Q4)²⁰Count$10,925,004 paid	at least 10,075 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$11,161,369 paid
semaglutideRybelsus®range 362 to 444, up 55 on the quarter before	at least 54 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$41,467 paid	at least 70 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$58,674 paid	at least 119 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$96,444 paid	at least 115 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$97,483 paid	at least 81 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$74,657 paid	at least 280 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$231,524 paid	at least 321 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$304,628 paid	at least 400 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$420,602 paid	at least 140 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$252,612 paid	at least 153 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$263,324 paid	at least 137 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$214,611 paid	at least 232 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$324,168 paid	410 paid prescriptions in the quarter (2024Q1)²⁷Count$491,936 paid	425 paid prescriptions in the quarter (2024Q2)²⁷Count$475,743 paid	at least 405 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$457,323 paid	425 paid prescriptions in the quarter (2024Q4)²⁷Count$514,231 paid	434 paid prescriptions in the quarter (2025Q1)²⁶Count$464,573 paid	444 paid prescriptions in the quarter (2025Q2)²⁶Count$505,369 paid	431 paid prescriptions in the quarter (2025Q3)²⁶Count$499,275 paid	362 paid prescriptions in the quarter (2025Q4)²⁶Count$423,326 paid	417 paid prescriptions in the quarter (2026Q1)²⁵Count$447,530 paid
liraglutideSaxenda®	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 96 to 953	808 paid prescriptions in the quarter (2021Q1)⁴²Count$827,310 paid	702 paid prescriptions in the quarter (2021Q2)⁴²Count$780,658 paid	885 paid prescriptions in the quarter (2021Q3)⁴²Count$853,301 paid	at least 277 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld⁴²At least$339,934 paid	953 paid prescriptions in the quarter (2022Q1)⁴¹Count$897,625 paid	659 paid prescriptions in the quarter (2022Q2)⁴¹Count$643,340 paid	556 paid prescriptions in the quarter (2022Q3)⁴¹Count$570,290 paid	524 paid prescriptions in the quarter (2022Q4)⁴¹Count$536,088 paid	at least 102 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld⁴⁰At least$163,372 paid	at least 105 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld⁴⁰At least$180,732 paid	327 paid prescriptions in the quarter (2023Q3)⁴⁰Count$354,705 paid	435 paid prescriptions in the quarter (2023Q4)⁴⁰Count$479,825 paid	274 paid prescriptions in the quarter (2024Q1)³⁹Count$246,162 paid	224 paid prescriptions in the quarter (2024Q2)³⁹Count$162,034 paid	96 paid prescriptions in the quarter (2024Q3)³⁹Count$72,695 paid	at least 47 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³⁹At least$39,957 paid	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³⁸Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	at least 14 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld³⁷At least$6,900 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable⁴⁵Withheld1 of 1 product codes withheld	at least 54 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$41,430 paid	at least 83 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$51,283 paid	at least 204 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$83,726 paid	at least 414 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$125,800 paid	at least 541 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$143,770 paid	at least 633 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$153,182 paid	at least 294 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$76,000 paid

What this page cannot tell you

Whether Nevada Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Nevada in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, NV
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state NV, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NV", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "325"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, NV
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state NV, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "75"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, NV
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state NV, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "product_name": "product_name like ZEPBOUND%, state NV, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, NV
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state NV, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "product_name": "product_name like ZEPBOUND%, state NV, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, NV
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state NV, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "product_name": "product_name like ZEPBOUND%, state NV, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, NV
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state NV, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "product_name": "product_name like ZEPBOUND%, state NV, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, NV
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state NV, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NV", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "1072"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, NV
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state NV, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "1181"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, NV
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state NV, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "810"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, NV
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state NV, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "184"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, NV
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state NV, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "114"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, NV
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state NV, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "product_name": "product_name like MOUNJARO%, state NV, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, NV
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state NV, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NV", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "129"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, NV
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state NV, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2025", "quarter": "2", "utilization_type": "FFSU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "88"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, NV
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state NV, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "21"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, NV
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state NV, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, NV
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state NV, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "product_name": "product_name like WEGOVY%, state NV, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, NV
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state NV, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "product_name": "product_name like WEGOVY%, state NV, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, NV
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state NV, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NV", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "3053"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, NV
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state NV, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "3820"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, NV
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state NV, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "3644"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, NV
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state NV, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1754"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, NV
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state NV, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1512"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, NV
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state NV, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "996"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, NV
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state NV, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NV", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "105"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, NV
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state NV, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "138"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, NV
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state NV, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "160"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, NV
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state NV, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "86"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, NV
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state NV, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "164"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, NV
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state NV, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "57"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, NV
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state NV, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NV", "product_name": "product_name like SAXENDA%, state NV, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, NV
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state NV, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "product_name": "product_name like SAXENDA%, state NV, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, NV
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state NV, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "product_name": "product_name like SAXENDA%, state NV, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, NV
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state NV, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "product_name": "product_name like SAXENDA%, state NV, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, NV
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state NV, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2022", "quarter": "2", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, NV
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state NV, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, NV
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state NV, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NV", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "14"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, NV
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state NV, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 2-", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, NV
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state NV, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "122"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, NV
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state NV, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "228"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, NV
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state NV, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "539"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, NV
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state NV, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2021", "quarter": "1", "utilization_type": "MCOU", "product_name": "Victoza 6M", "suppression_used": "false", "number_of_prescriptions": "447"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, NV
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state NV, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NV", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "94"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, NV
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state NV, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "294"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, NV
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state NV, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "47"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, NV
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state NV, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "product_name": "product_name like LIRAGLUTID%, state NV, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, NV
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state NV, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "product_name": "product_name like LIRAGLUTID%, state NV, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, NV
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state NV, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NV", "product_name": "product_name like LIRAGLUTID%, state NV, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 34 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 14 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Nevada Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.